A share price of Inovio Pharmaceuticals Inc [INO] is currently trading at $11.32, up 3.38%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The INO shares have gain 12.41% over the last week, with a monthly amount glided 44.94%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Inovio Pharmaceuticals Inc [NASDAQ: INO] stock has seen the most recent analyst activity on May 14, 2024, when Stephens initiated its Overweight rating and assigned the stock a price target of $20. Previously, Oppenheimer upgraded its rating to Outperform on January 25, 2024, and kept the price target unchanged to $4. On November 09, 2022, downgrade downgraded it’s rating to Hold. BofA Securities downgraded its rating to a Underperform but stick to its price target of $2 on November 01, 2022. Oppenheimer downgraded its rating to Perform for this stock on May 11, 2022. In a note dated January 21, 2022, BofA Securities upgraded an Neutral rating on this stock and boosted its target price from $8 to $10.
Inovio Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $3.89 and $14.75. Currently, Wall Street analysts expect the stock to reach $30 within the next 12 months. Inovio Pharmaceuticals Inc [NASDAQ: INO] shares were valued at $11.32 at the most recent close of the market. An investor can expect a potential return of 165.02% based on the average INO price forecast.
Analyzing the INO fundamentals
Trailing Twelve Months sales for Inovio Pharmaceuticals Inc [NASDAQ:INO] were 0.72M which represents -100.00% decline. Gross Profit Margin for this corporation currently stands at -3.34% with Operating Profit Margin at -183.35%, Pretax Profit Margin comes in at -174.23%, and Net Profit Margin reading is -174.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.97, Equity is -0.96 and Total Capital is -1.24. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.14.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.77 points at the first support level, and at 10.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.10, and for the 2nd resistance point, it is at 12.88.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Inovio Pharmaceuticals Inc [NASDAQ:INO] is 4.77. Further, the Quick Ratio stands at 4.77, while the Cash Ratio is 0.84. Considering the valuation of this stock, the price to sales ratio is 407.36, the price to book ratio is 2.80.
